Web1 day ago · Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic … WebApr 14, 2024 · The stock has a market cap of $13.14 billion, a price-to-earnings ratio of 51.89, a PEG ratio of 2.39 and a beta of 1.25. The company has a quick ratio of 3.15, a …
National Bank of Canada FI Acquires 4,472 Shares of Bio-Techne …
WebApr 12, 2024 · MINNEAPOLIS, April 12, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and … WebApr 13, 2024 · Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery … chimy\\u0027s cerveceria
Prostate cancer test leads Bio-Techne
WebApr 12, 2024 · The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips. BIO-TECHNE Corp’s Stock Price as of Market Close. As of April 12, 2024, 4:00 PM CST, BIO-TECHNE Corp’s stock price was $81.22. BIO-TECHNE Corp is up 4.4% from its previous closing price of $77.80. ... WebApr 12, 2024 · The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips. BIO-TECHNE Corp’s Stock Price as … WebApr 14, 2024 · The fund owned 4,621 shares of the biotechnology company's stock after pu. National Bank of Canada FI raised its holdings in shares of Bio-Techne Co. … chimy\u0027s cerveceria